DK0494317T3 - SIV-cpz-ant-retrovirus og anvendelse deraf - Google Patents

SIV-cpz-ant-retrovirus og anvendelse deraf

Info

Publication number
DK0494317T3
DK0494317T3 DK90111364.7T DK90111364T DK0494317T3 DK 0494317 T3 DK0494317 T3 DK 0494317T3 DK 90111364 T DK90111364 T DK 90111364T DK 0494317 T3 DK0494317 T3 DK 0494317T3
Authority
DK
Denmark
Prior art keywords
virus
protein
ant
htlv
lysates
Prior art date
Application number
DK90111364.7T
Other languages
English (en)
Other versions
DK0494317T4 (da
Inventor
Peter Prof Dr Piot
Guido Van Der Dr Sc Groen
Eric Dr Delaporte
Martine Dr Peeters
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8204103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0494317(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of DK0494317T3 publication Critical patent/DK0494317T3/da
Application granted granted Critical
Publication of DK0494317T4 publication Critical patent/DK0494317T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90111364T 1990-06-15 1990-06-15 SIV cpz-ant-retrovirus og anvendelse deraf DK0494317T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90111364A EP0494317B2 (en) 1990-06-15 1990-06-15 The retrovirus SIV cpz-ant and its uses

Publications (2)

Publication Number Publication Date
DK0494317T3 true DK0494317T3 (da) 1994-10-10
DK0494317T4 DK0494317T4 (da) 2001-04-02

Family

ID=8204103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90111364T DK0494317T4 (da) 1990-06-15 1990-06-15 SIV cpz-ant-retrovirus og anvendelse deraf

Country Status (10)

Country Link
US (1) US5624795A (da)
EP (1) EP0494317B2 (da)
JP (1) JPH06500230A (da)
AT (1) ATE105857T1 (da)
AU (1) AU657479B2 (da)
CA (1) CA2085370A1 (da)
DE (1) DE69009066T3 (da)
DK (1) DK0494317T4 (da)
ES (1) ES2053014T5 (da)
WO (1) WO1991019785A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470572A (en) * 1993-07-16 1995-11-28 University Of Puerto Rico Non-infectious simian immunodeficiency virus particles produced by cell line CRL 11393
WO2003062377A2 (en) * 2002-01-17 2003-07-31 The Uab Research Foundation COMPLETE GENOME SEQUENCE OF SIVcpzTAN1
US9644187B2 (en) 2010-04-14 2017-05-09 Emd Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588248T2 (de) † 1984-10-18 2004-07-01 Institut Pasteur LAV-Antigene und -Peptide
EP0320495B1 (fr) † 1986-01-22 2000-08-02 Institut Pasteur Procédé de fabrication récombinante des protéines derivées de HIV-2 et culture cellulaire exprimant des protéines de HIV-2
WO1989009815A1 (en) * 1988-04-04 1989-10-19 Research Corporation Technologies, Inc. Novel virus of the hiv-2 family and methods of detection therefor
ES2072853T3 (es) * 1988-06-09 1995-08-01 Innogenetics Nv Retrovirus hiv-3 y su utilizacion.
FR2644176B1 (fr) † 1989-03-07 1993-10-08 Franceville Ctre Internal Recher Retrovirus viscpz infectant naturellement le chimpanze, fragments d'adn de ce retrovirus, procede de preparation d'une proteine et/ou d'une enzyme de ce virus et leurs utilisations

Also Published As

Publication number Publication date
DE69009066D1 (de) 1994-06-23
ES2053014T5 (es) 2001-02-16
EP0494317B2 (en) 2000-12-27
EP0494317A1 (en) 1992-07-15
WO1991019785A1 (en) 1991-12-26
DE69009066T2 (de) 1994-10-06
CA2085370A1 (en) 1991-12-16
AU657479B2 (en) 1995-03-16
US5624795A (en) 1997-04-29
JPH06500230A (ja) 1994-01-13
ATE105857T1 (de) 1994-06-15
ES2053014T3 (es) 1994-07-16
DK0494317T4 (da) 2001-04-02
EP0494317B1 (en) 1994-05-18
DE69009066T3 (de) 2001-07-19
AU7967091A (en) 1992-01-07

Similar Documents

Publication Publication Date Title
DK0413622T3 (da) Albuminderivater med terapeutiske virkninger
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
WO1990015066A3 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
DE3855947D1 (de) Peptide mit den immunologischen Eigenschaften von HIV-2
EP2267452B8 (en) A soluble complex comprising a retroviral surface glycoprotein
DK33190D0 (da) Hiv-3 retrovirus og anvendelse heraf
DE3855134D1 (de) Monoklonale menschliche antikörper gegen hiv-i
DK0494317T3 (da) SIV-cpz-ant-retrovirus og anvendelse deraf
Dirckx et al. Mutation of conserved N-glycosylation sites around the CD4-binding site of human immunodeficiency virus type 1 GP120 affects viral infectivity
ATE159983T1 (de) Monoklonaler antikörper gegen htlv-iii (stamm mn)
ES2058259T3 (es) Antigenos sinteticos para la deteccion de enfermedad relacionada con sida causada por lav-2.
ES2195200T3 (es) Construccion de peptidos de rama multiples.
Shinji et al. Clonal analysis of functional differences among strains of human immunodeficiency virus (HIV)
DE59100308D1 (de) Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren.
FR2647809B1 (fr) Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus
FR2632310B1 (fr) Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
EP0250128A3 (en) Novel virus isolated from patients with aids
DK0424519T3 (da) Antigeneer fra det transmembranale kappeglycoprotein fra et humant retrovirus af HIV-2-typen samt an tigener, der har et immunologisk slægtskab dermed
KR900005991A (ko) 옥트레오티드(Octreotide)를 함유한 약학적 조성물
FR2614025B1 (fr) Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida
Goldstein et al. A macaque adherent cell line that expresses human CD4 is susceptible to SIV: utility for assessing neutralizing antibody
DK0569428T3 (da) Fremgangsmåde til diagnosticering in vitro af HIV-1-virusinfektioner
DK410189A (da) Farmaceutisk praeparat til inhibering af infektion med vira, som fremkalder aids
Dianzani et al. Evaluation of the antiviral effect of new compounds by using cellular cultures
FR2652091B1 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in-vitro des infections dues a ces virus.